Search

everythinglearnresearchcommunity

for

Search:↓

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Finasteride for hair loss may cause depression, affecting sleep and relationships.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Finasteride effectively treats central serous chorioretinopathy.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

A woman's hair changed to a dry, tangled texture that's hard to comb after treatment with spironolactone, suggesting the medication might cause such hair changes.